Eli J. Larson

Structural O-Glycoform Heterogeneity of the SARS-CoV-2 Spike Protein Receptor-Binding Domain Revealed by Top-Down Mass Spectrometry

David S. Roberts, Morgan Mann, Jake A. Melby et al. · Journal of the American Chemical Society · 2021 · 78 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

High sensitivity top–down proteomics captures single muscle cell heterogeneity in large proteoforms

Jake A. Melby, Kyle A. Brown, Zachery R. Gregorich et al. · Proceedings of the National Academy of Sciences · 2023 · 66 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

Simulation of elution profiles in liquid chromatography − II: Investigation of injection volume overload under gradient elution conditions applied to second dimension separations in two-dimensional liquid chromatography

Dwight R. Stoll, Ray Sajulga, Bryan Voigt et al. · Journal of Chromatography A · 2017 · 60 citations

Pharmacy, Chemical Engineering, Chemistry +17

High-Throughput Multi-attribute Analysis of Antibody-Drug Conjugates Enabled by Trapped Ion Mobility Spectrometry and Top-Down Mass Spectrometry

Eli J. Larson, David S. Roberts, Jake A. Melby et al. · Analytical Chemistry · 2021 · 59 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Optimization of a two-dimensional liquid chromatography-supercritical fluid chromatography-mass spectrometry (2D-LC-SFC-MS) system to assess “in-vivo” inter-conversion of chiral drug molecules

Meenakshi Goel, Eli J. Larson, Cadapakam J. Venkatramani · Journal of Chromatography B · 2018 · 38 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +14